REG - Cambridge Nutrition. - Grant of Options

Cambridge Nutritional SciencesAnnouncement

08/04/2025 07:00

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20250408:nRSH0801Ea&default-theme=true

RNS Number : 0801E  Cambridge Nutritional Sciences PLC  08 April 2025

Cambridge Nutritional Sciences plc

(the 'Company' or 'CNS')

 

Grant of Options

CNS (AIM: CNSL), the specialist medical diagnostics company focused on
promoting a personalised and functional approach to health and nutrition,
 announces that on 31(st) March 2025 the Board granted share options (the
"Options") over its ordinary shares of 4 pence each ("Ordinary Shares") to
James Cooper, Chief Executive Officer and Executive Director.

Following this grant of Options, the Company has options in issue over
26,173,182 Ordinary Shares, representing approximately 11.0% per cent. of the
Company's total issued share capital.

 Director      Number of Options granted on  Exercise Price  Total options held

 31(st) March 2025
post issue
 James Cooper  2,500,000                     4p              4,500,000

 

Grant of Options

The Company has granted the Options to incentivise executive director
performance for the benefit of all Shareholders.

The Options are subject to time conditions (as set out below); good/bad leaver
provisions; and being a director of the Company on the date of vesting.

 

Options are subject to time conditions as follows:

 Proportion of Options           Normal earliest exercise date
 34 per cent. ("Tranche One")    On the second anniversary of 31(st) March 2025
 33 per cent. ("Tranche Two")    On the third anniversary of 31(st) March 2025
 33 per cent. ("Tranche Three")  On the fourth anniversary of 31(st) March 2025

 

For further information, please contact:

 Cambridge Nutritional Sciences Plc               www.cnsplc.com (http://www.cnsplc.com/)

 James Cooper, Chief Executive Officer            investors@cnsplc.com

 Cavendish Capital Markets Limited                Tel: 020 7220 0500

 Geoff Nash / Edward Whiley (Corporate Finance)

 Nigel Birks / Harriet Ward (ECM)

 

About Cambridge Nutritional Sciences Plc

Cambridge Nutritional Sciences Plc (AIM: CNSL) is the specialist medical
diagnostics company focused on promoting a personalised and functional
approach to health and nutrition.

 

Notification and public disclosure of transactions by persons discharging
managerial responsibilities and persons closely associated with them

 1   Details of the person discharging managerial responsibilities/person closely
     associated
 a)   Name                                    James Cooper
 2.  Reason for the notification
 a)  Position/status                          Chief Executive Officer, Executive Director
 b)  Initial notification/                    Initial Notification

Amendment
 3.  Details of the issuer, emission allowance market participant, auction
     platform, auctioneer or auction monitor
 a)  Name                                     Cambridge Nutritional Sciences plc
 b)  LEI                                      2138007U9P4BTZTYIR92
 4.  Details of the transaction(s): section to be repeated for (i) each type of
     instrument; (ii) each type of transaction; (iii) each date; and (iv) each
     place where transactions have been conducted
 a)  Description of the                       Options over Ordinary Shares of 4p each

financial instrument
     Identification code                      ISIN: GB00B1VCP282
 b)  Nature of                                Grant of Options

the transaction
 c)  Price(s) and volume(s)                   Price(s)           Volume(s)
                                              4p exercise price  2,500,000
 d)  Aggregated information                    As above

     - Aggregated volume

     - Price
 e)  Date of the                              31(st) March 2025

transactions
 f)  Place of the transactions                Outside a trading venue

d)

Aggregated information

- Aggregated volume

- Price

 As above

e)

Date of the

transactions

31(st) March 2025

f)

Place of the transactions

Outside a trading venue

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  DSHGUGDSRDGDGUI